<DOC>
	<DOCNO>NCT02604537</DOCNO>
	<brief_summary>The purpose study determine corticosteriod injection modify natural course de Quervain tendinopathy compare toradol injection .</brief_summary>
	<brief_title>Celestone Versus Ketorolac Injection Treatment DeQuervains Tenosyovitis</brief_title>
	<detailed_description />
	<mesh_term>Tendinopathy</mesh_term>
	<mesh_term>Lidocaine</mesh_term>
	<mesh_term>Ketorolac</mesh_term>
	<mesh_term>Ketorolac Tromethamine</mesh_term>
	<mesh_term>Betamethasone benzoate</mesh_term>
	<mesh_term>Betamethasone-17,21-dipropionate</mesh_term>
	<mesh_term>Betamethasone</mesh_term>
	<mesh_term>Betamethasone Valerate</mesh_term>
	<mesh_term>Epinephrine</mesh_term>
	<mesh_term>Racepinephrine</mesh_term>
	<mesh_term>Epinephryl borate</mesh_term>
	<mesh_term>Betamethasone sodium phosphate</mesh_term>
	<criteria>Diagnosis deQuervain tendinopathy Understands local language willing able follow requirement protocol Understands informed consent sign institutional review board/independent ethic committee ( IRB/IEC ) approve informed consent form Patients allergy lidocaine , celestone , ketorolac , NSAIDS , ASA Patients adverse reaction lidocaine , celestone , ketorolac ( severe elevation blood sugar diabetic cause medical complication ) Patients receive prior steriod injection within past three month Patients prior ipsilateral surgery De ! uervains Tenosyovitis Patients skin lesion location injection ( trauma , eczema , rash ) Patients current infection location injection Patients iontophoresis within three month Patients breast feeding , pregnant , plan become pregnant next six month</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2017</verification_date>
</DOC>